7 employees
Seal Rock Therapeutics is a developer of small molecule inhibitors used to treat inflammatory and fibrotic conditions.
2016
Seal Rock Therapeutics raised undisclosed on January 1, 2018
Investors: Life Science Angels
Seal Rock Therapeutics raised undisclosed on January 1, 2017